Skip to content

Lusutrombopag

Published: July 26, 2026Updated: July 26, 2026

Mulpleta is a thrombopoietin receptor agonist used to treat thrombocytopenia (low platelet count) in adults with chronic liver disease. It works by stimulating the bone marrow to produce more platelets, helping to reduce the risk of bleeding during or after scheduled procedures. This medication is specifically indicated for patients who require a procedure but have low platelet counts that would otherwise pose a bleeding risk.

Quick summary

Mulpleta is a platelet-boosting medication for adults with chronic liver disease who have low platelet counts and need to undergo a medical procedure.

Medically reviewed by WellAlly Editorial TeamLast reviewed July 26, 2026Editorial policy

Key facts at a glance

RxNorm
2054990
Generic
Mulpleta
Class
brand-name
Brands
—
Availability
rx
Lactation
unknown
Routes
—
Forms
—
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Mulpleta is indicated for the treatment of thrombocytopenia in adults with chronic liver disease who are scheduled to undergo a medical, surgical, or dental procedure. It is used to increase platelet counts to reduce the risk of bleeding associated with procedures.

Mulpleta contains the active ingredient lusutrombopag, which is a thrombopoietin receptor agonist. It binds to and activates the thrombopoietin receptor on bone marrow cells, stimulating the production and maturation of platelets.

Mulpleta is typically taken orally once daily for a limited duration before a scheduled procedure. Patients should be monitored for platelet counts and signs of thrombosis (blood clots) during treatment. The medication is contraindicated in patients with known hypersensitivity to lusutrombopag or any inactive ingredients.

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed July 26, 2026. · Read our editorial policy